@FiercePharma: Zytiga wins European approval for earlier use. FDA did the same in December. Could be big for Janssen/J&J. More | Follow @FiercePharma
@AlisonBFierce: Widespread flu outbreak gives vaccine manufacturers a shot in the arm. News | Follow @AlisonBFierce
> European regulators approved a big expansion in the use of Johnson & Johnson's ($JNJ) prostate cancer pill Zytiga, following the FDA's similar approval last month. Report
> Makers of over-the-counter flu and cold remedies are benefiting from this year's unusually strong flu season. Report
> Novartis ($NVS) says a new late-stage trial found that its meningitis vaccine Bexsero delivered a protective immune response in infants with a three-dose regimen, with additional effect after a booster in toddlers. Report
> GlaxoSmithKline ($GSK) has drawn the ire of small suppliers with new 90-day payment terms, which the company says are consistent with its corporate peers. Report
> As Roche ($RHHBY) prepares to pull out of Nutley, NJ, it's receiving offers for the 119-acre property and working to find jobs for laid-off workers. Report
> Lundbeck recruited Bayer Healthcare's Barbara Jaszewski to be its senior VP of global product strategy and portfolio development. Report
> Astellas Pharma won European approval for its overactive bladder treatment, Betmiga. Report
Biotech News
@FierceBiotech: Trending on FierceBiotech.com: $GSK pilots 6th drug to regulators in R&D offensive. More | Follow @FierceBiotech
@JohnCFierce: Activists cry havoc, let slip the dogs of war on AstraZeneca. News | Follow @JohnCFierce
@RyanMFierce: PatientsLikeMe tackles extremely rare genetic disease. Item | Follow @RyanMFierce
> Eisai's pivotal hopes for ovarian cancer drug dashed by PhIII flop. Story
> Aileron snags $12M to fuel first human study of 'stapled' peptide. Article
@FierceMedDev: Experts: Odds of device tax repeal close to zero. Item | Follow @FierceMedDev
@MarkHFierce: Covidien begins postapproval study for stroke treatment device. More | Follow @MarkHFierce
@DamianFierce: Last thing from JPM13: Talking Chinese outsourcing with Vertex, Merck, MedImmune and WuXi. Story | Follow @DamianFierce
> J&J's other hip device lands it back in court. Story
Biotech IT News
> How 'open' will Big Pharma get to treat R&D ills? Item
> Computer game rewards players for shirking flu shots. Report
> Elsevier snaps up drug R&D software company. Article
> Illumina, Life Tech trumpet startup efforts in clinical genomics. News
CRO News
> Report: Indian drug-related trial deaths rose in 2012. Report
> goBalto inks deal with INC for trial software. Article
> Catalent breathes $20M into inhalant business. News
> GVK partners with Onconova on cancer drugs. Story
> Parexel chief named ACRO chairman. Item
And Finally... Stroke survivors with depression are four times more likely to die than those who aren't depressed. Report